Physician profile
Taylor Bergstrom
NPI 1457937187
$1,229.58
in general payments reported to CMS, 2019-2025
12 companies · $259 in 2025
The $259 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $971 · 2025: $259.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,069 · Travel and Lodging: $161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,068.63 |
| Travel and Lodging | $160.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $490.00 | 2024-2025 | Augment Injectable, Ortholoc 3di, Gravity Synchfix |
| Integra Lifesciences Corporation | $231.48 | 2024-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Arthrex, INC. | $184.95 | 2024 | |
| Amgen INC. | $58.69 | 2024-2025 | Krystexxa |
| Becton, Dickinson and Company | $50.42 | 2024 | Venclose Maven Catheter |
| Orthofix Medical, INC. | $49.71 | 2024-2025 | Spinal-Stim, Physio-Stim |
| Organogenesis INC. | $49.34 | 2024 | |
| Medtronic, INC. | $30.79 | 2025 | Intellis Adaptivestim |
| Depuy Synthes Sales INC. | $25.43 | 2024 | |
| Treace Medical Concepts, INC. | $24.08 | 2024 | |
| Surgenex LLC | $20.47 | 2025 | Surmatrix, Renograft, Ardeograft |
| Fidia Pharma USA INC. | $14.22 | 2025 | Hymovis, Triluron |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taylor Bergstrom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.